Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cancer drugs
Pharma
AstraZeneca inks $1.35B deal for subcutaneous cancer drugs
AstraZeneca signed the Alteogen collaboration despite an escalating patent dispute around the Korean company's ALT-B4 subcutaneous drug delivery tech.
Angus Liu
Mar 17, 2025 10:55am
Roche settles UPenn patent lawsuit over breast cancer drugs
Mar 14, 2025 3:00pm
Axplora to boost ADC production capacity at French facility
Mar 5, 2025 9:53am
Merck KGaA confirms interest in acquiring SpringWorks
Feb 11, 2025 8:15am
Lantheus snaps up radiopharma CDMO Evergreen for $250M+
Jan 28, 2025 10:08am
Novartis to close 2 MorphoSys sites, lay off 330 staffers
Dec 19, 2024 9:47am
